Adiposogenital dystrophy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 27: Line 27:




==Presentation==
==[[Adiposogenital dystrophy overview|Overview]]==
It is characterized by:
* Feminine [[obesity]]
* [[Growth retardation]] and retarded [[sexual development]], [[atrophy]] or [[hypoplasia]] of the [[gonads]], and altered [[secondary sex characteristics]],
* [[headaches]]
* [[mental retardation]], problems with [[Visual perception|vision]]
* [[polyuria]], [[polydipsia]].


It is usually associated with [[tumor|tumours]] of the [[hypothalamus]], causing increased [[appetite]] and depressed [[secretion]] of [[gonadotropin]]. It seems to affect [[males]] mostly.
==[[Adiposogenital dystrophy historical perspective|Historical Perspective]]==


Many overweight children may appear to have the disorder because of the concurrence of obesity and retarded sexual development; these children have no [[endocrine]] disturbances, however, and they mature normally after delayed [[puberty]].
==[[Adiposogenital dystrophy classification|Classification]]==


==Synonyms==
==[[Adiposogenital dystrophy pathophysiology|Pathophysiology]]==


==[[Adiposogenital dystrophy causes|Causes]]==


==See also==
==[[Adiposogenital dystrophy differential diagnosis|Differentiating Adiposogenital dystrophy from other Diseases]]==
* [[Prader-Willi syndrome]], to which it might resemble. However, this is a [[genetic disorder]].


==References==
==[[Adiposogenital dystrophy epidemiology and demographics|Epidemiology and Demographics]]==
{{reflist|2}}
 
==[[Adiposogenital dystrophy risk factors|Risk Factors]]==
 
==[[Adiposogenital dystrophy screening|Screening]]==
 
==[[Adiposogenital dystrophy natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
==Diagnosis==
[[Adiposogenital dystrophy history and symptoms|History and Symptoms]] | [[Adiposogenital dystrophy physical examination|Physical Examination]] | [[Adiposogenital dystrophy laboratory findings|Laboratory Findings]] | [[Adiposogenital dystrophy molecular_genetic_studies|Molecular Genetic Studies]] | [[Adiposogenital dystrophy genotyping|Genotyping]] | [[Adiposogenital dystrophy pelvic x ray|Pelvic X Ray]] | [[Adiposogenital dystrophy CT|CT]] | [[Adiposogenital dystrophy ultrasound|Ultrasound]] | [[Adiposogenital dystrophy other imaging findings|Other Imaging Findings]] | [[Adiposogenital dystrophy other diagnostic studies|Other Diagnostic Studies]]
 
==Treatment==
[[Adiposogenital dystrophy medical therapy|Medical Therapy]] | [[Adiposogenital dystrophy primary prevention|Primary Prevention]] | [[Adiposogenital dystrophy secondary prevention|Secondary Prevention]] | [[Adiposogenital dystrophy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] |  [[Adiposogenital dystrophy future or investigational therapies|Future or Investigational Therapies]]
 
==Case Studies==
 
[[Adiposogenital dystrophy case study one|Case #1]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}





Revision as of 15:03, 20 September 2012

Adiposogenital dystrophy
ICD-10 E23.6
ICD-9 253.8
DiseasesDB 29318

For patient information, click here

Adiposogenital dystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adiposogenital dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Head X Ray

CT

MRI

Vision Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adiposogenital dystrophy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adiposogenital dystrophy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adiposogenital dystrophy

CDC on Adiposogenital dystrophy

Adiposogenital dystrophy in the news

Blogs on Adiposogenital dystrophy

Directions to Hospitals Treating Adiposogenital dystrophy

Risk calculators and risk factors for Adiposogenital dystrophy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Synonyms and keywords:: Froehlich syndrome; frohlich syndrome; hypothalamic infantilism with obesity syndrome. It has several other names:[1]


Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adiposogenital dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Molecular Genetic Studies | Genotyping | Pelvic X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Template:WikiDoc Sources


de:Fröhlich-Syndrom


Template:WikiDoc Sources

  1. National Organisation for Rare Disorders - Froelich's syndrome
  2. Template:WhoNamedIt - Babinski-Fröchlich syndrome
  3. J. F. Babinski. Tumeur du corps pituitaire sans acromégalie et avec arrêt de développement des organes génitaux. Revue neurologique, Paris, 1900, 8: 531-535.
  4. A. Fröhlich. Ein Fall von Tumor der Hypophysis cerebri ohne Akromegalie. Wiener klinische Rundschau, 1901, 15: 833-836; 906-908.
  5. Zárate A, Saucedo R (2007). "[The adiposogenital distrophy or Frohlich syndrome and the beginning of the concept of neuroendocrinology]". Gac Med Mex (in Spanish; Castilian). 143 (4): 349–50. PMID 17969845.